Total raised
—
Last: Undisclosed
Stage
Seed
Founded
2011
Headcount
18,600
HQ
Ness Ziona
Sector
Health Tech & Life Sciences
About
ProMining Therapeutics Ltd discovers and develops novel oral, small-molecule drugs for the treatment of cancer, inflammation, chronic pain, and cardiovascular and viral diseases. The company developed CavitIIRx, a proprietary drug-discovery and development platform focused on SH3 domain-mediated proteinprotein interactions known to play a major role in numerous disease mechanisms. ProMining uses its innovative platform to discover promising drug candidate molecules, creating a pipeline of drugs in development and accelerating the drug-discovery process.
Funding history · 1 round · — total
Date unknown
Undisclosed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
viral-diseasesdrug-discoverychronic-paintargeted-cancer-therapycardiovascularpharma-companiescardiology